| Year |
Citation |
Score |
| 2024 |
Nandoliya KR, Thirunavu V, Ellis E, Dixit K, Tate MC, Drumm MR, Templer JW. Pre-operative predictors of post-operative seizure control in low-grade glioma: a systematic review and meta-analysis. Neurosurgical Review. 47: 94. PMID 38411788 DOI: 10.1007/s10143-024-02329-9 |
0.382 |
|
| 2023 |
Johnson M, Bell A, Lauing KL, Ladomersky E, Zhai L, Penco-Campillo M, Shah Y, Mauer E, Xiu J, Nicolaides T, Drumm M, McCortney K, Elemento O, Kim M, Bommi P, et al. Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37725593 DOI: 10.1158/1078-0432.CCR-23-0834 |
0.496 |
|
| 2023 |
Drumm M, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, Webb BT, Byrne KT, Unruh D, Thirunavu V, Walshon J, Steffens A, McCortney K, Lukas RV, Phillips JJ, et al. Postoperative risk of IDH mutant glioma-associated seizures and their potential management with IDH mutant inhibitors. The Journal of Clinical Investigation. PMID 37104042 DOI: 10.1172/JCI168035 |
0.546 |
|
| 2022 |
Burdett KB, Unruh D, Drumm M, Steffens A, Lamano JB, Judkins J, Schwartz M, Javier R, Amidei C, Lipp ES, Peters KB, Lai A, Eldred BSC, Heimberger AB, McCortney K, et al. Determining venous thromboembolism risk in patients with adult-type diffuse glioma. Blood. PMID 36399711 DOI: 10.1182/blood.2022017858 |
0.549 |
|
| 2022 |
Javier R, Wang W, Drumm M, McCortney K, Sarkaria JN, Horbinski C. The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma. Plos One. 17: e0257725. PMID 35134075 DOI: 10.1371/journal.pone.0257725 |
0.525 |
|
| 2022 |
Drumm M, Templer JW, Tate M, Jennings L, Horbinski C. Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation. Neuro-Oncology Advances. 4: vdac004. PMID 35128400 DOI: 10.1093/noajnl/vdac004 |
0.534 |
|
| 2020 |
Drumm MR, Dixit KS, Grimm S, Kumthekar P, Lukas RV, Raizer JJ, Stupp R, Chheda MG, Kam KL, McCord M, Sachdev S, Kruser T, Steffens A, Javier R, McCortney K, et al. Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas. Neuro-Oncology. 22: 470-479. PMID 31711239 DOI: 10.1093/Neuonc/Noz216 |
0.557 |
|
| 2019 |
Unruh D, Zewde M, Buss A, Drumm MR, Tran AN, Scholtens DM, Horbinski C. Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers. Scientific Reports. 9: 8946. PMID 31222125 DOI: 10.1038/S41598-019-45346-1 |
0.471 |
|
| 2018 |
Unruh D, Mirkov S, Wray B, Drumm M, Lamano J, Li YD, Haider QF, Javier R, McCortney K, Saratsis AM, Scholtens DM, Sarkaria JN, James CD, Horbinski C. Methylation-dependent Tissue Factor suppression contributes to the reduced malignancy of IDH1 mutant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30266764 DOI: 10.1158/1078-0432.Ccr-18-1222 |
0.503 |
|
| Show low-probability matches. |